Dolutegravir-based therapy, diet, physical activity and weight gain: a 48-week prospective cohort in South Africa. Tien D, Chandiwana N, Shazi G, Chen G, et al. J Acquir Immune Defic Syndr 2025 Dec 2. doi: 10.1097/QAI.0000000000003812.

Read + Share

Amedeo Smart

Independent Medical Education

Tien D, Chandiwana N, Shazi G, Chen G, et al. Dolutegravir-based therapy, diet, physical activity and weight gain: a 48-week prospective cohort in South Africa. J Acquir Immune Defic Syndr 2025 Dec 2. doi: 10.1097/QAI.0000000000003812.
PMID: 41329528